Other studies have shown that patterns of antibody responses to nonviral cancer antigens (such as LAGE-1, MAGE-A1 etc.)are distinct based upon HPV status which can be utilized for the development of immunotherapy for HNSCC [44]. This evidence concerns the gene CTAG2 and cancer.